Nigel F. Maynard

Editorial Director
Send a Message

Author Profile

Nigel F. Maynarad is editor in chief and editorial director of Drug Store News. 



All about the fees: Will the new federal rule on reimbursement go far enough?

DSN editor in chief Nigel Maynard reveals how DIR fees are seen as the most challenging issue the industry faces.

Survey: How important are mid-tier brands to retail stores?

Please take our survey below to help us get the real story.

Products to Watch: HRG’s 5 notable products from April 2022

Discover which items stood out from the 220 product launches HRG’s new product team reviewed last month.

NACDS Foundation presents more than $220K in scholarships to improve patient care

The program recognizes 10 schools and colleges of pharmacy for their innovative and diverse educational programs.

Do retail health clinicians help sell products?

Clinicians are estimated to recommend products to as many as 25 people a day.

Rising to the occasion: As competitors muddy the field, retail pharmacy must remain focused on its differentiator

In his latest column, DSN editor and chief Nigel Maynard points to retail pharmacy’s biggest advantage in its arsenal of tools when competing with rivals.

Products to Watch: HRG’s top 5 selections from March 2022

Out of 220 new products that hit shelves in March, HRG’s new product team found five that stood out.

Drug Store News assembles new editorial advisory board with retail pharmacy leaders

The first editorial advisory board is made up of executives from leading retailers, suppliers and associations.

Problem solvers: Sure, retail pharmacy has challenges, but great minds are exploring solutions

DSN editor in chief Nigel Maynard shares how a panel of consultants, suppliers and pharmacy executives discussed possible solutions to some of the issues the industry is facing.

Products to Watch: HRG’s top 5 choices from February 2022

HRG’s new product team sifted through 172 products introduced last month to find five that have the potential to be lasting offerings.